Critics hope new cabinet will put a stop to drug-price regulation changes

Advertisement

Advertise with us

OTTAWA - Critics of a major drug-price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January.

Read this article for free:


By clicking the button above, an account will be created and you will begin to receive some of our recommended newsletters. You may opt out of any newsletter by visiting your Email and Communication Preferences page or by clicking "unsubscribe" at the bottom of any email.

or

Already have an account? Log in here »

To continue reading, please subscribe:

Digital Subscription

One year of digital access for only $1.44 a week*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*Billed as $5.77 plus GST every four weeks. After 52 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 28/10/2021 (1827 days ago), so information in it may no longer be current.

OTTAWA – Critics of a major drug-price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January.

The Patented Medicine Prices Review Board (PMPRB) is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs.

The overhaul has drawn the disapproval of patient groups and drug manufacturers, as well as some pharmacists, doctors, academics and even provincial governments.

A shelf of drugs at a pharmacy in Quebec City on March 8, 2012. Critics of a major drug-price overhaul hope a new federal cabinet will put a temporary stop to the new regulations set to come into effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug prices. THE CANADIAN PRESS/Jacques Boissinot
A shelf of drugs at a pharmacy in Quebec City on March 8, 2012. Critics of a major drug-price overhaul hope a new federal cabinet will put a temporary stop to the new regulations set to come into effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug prices. THE CANADIAN PRESS/Jacques Boissinot

On Tuesday, Prime Minister Justin Trudeau put a new minister, Jean-Yves Duclos, in charge of Health Canada, which oversees the file.

“I think it’s premature and even irresponsible for anybody to be making any decisions until the new senior policy-makers for government are in place and have a chance to settle in and be briefed and to hear from stakeholders,” said John Adams, the volunteer board chair of the Best Medicines Coalition.

The coalition lobbies on behalf of 29 patient groups for access to safe, effective medicines.

While most welcome more affordable drugs, some critics fear a drastic drop in the sticker price for medicines will make Canada an unattractive place to launch new products, which could leave life-saving new therapies out of reach for Canadian patients.

The changes could also put pressure on the supply of existing drugs to Canada, Adams said.

Health Canada first announced the changes in 2019 as a means to protect Canadians from excessive prices and make patented medicines more affordable.

The department expects the amendments will save Canadians billions of dollars over the next 10 years on patented drugs.

Adams calls it a “hazardous public policy experiment.”

Health Canada said there is no evidence lower drug prices will reduce access to medicines.

“With these changes, Canada will continue to be an important market for new medicines,” a Health Canada spokeswoman wrote in a statement to The Canadian Press.

“New medicines are launched in major markets in very similar time frames, including in countries with prices below those in Canada.”

Since the policy was announced, the agency has become embroiled in court challenges against pharmaceutical companies and even the Quebec government, which claims the regulations are unconstitutional. Those cases are ongoing.

Other critics worry about stifling effects on innovation in the biomedical field.

A coalition of eight Canadian life-sciences organizations have written to government ministers to ask them to put off the changes pending further consultation, input from the new federal cabinet, and resolution of the legal challenges.

“We strongly recommend waiting until new ministers and other political appointments have been made, mandate letters have been issued, and decision-makers have been briefed on this issue before moving forward,” the life-science organizations wrote in their letter earlier this month.

The organizations said the changes run contrary to the federal biomanufacturing and life sciences strategy, announced last summer, which strives to enable innovation by ensuring “world class regulation.”

One of the signatories, Jason Field, president and CEO Life Sciences Ontario, said he was encouraged by the strategy and the impact it could have on the government’s decisions on the PMPRB changes.

“I am hopeful and optimistic a new cabinet will want to prioritize that life sciences strategy,” Field said in an interview with The Canadian Press.

Minister of Innovation, Science and Industry Francois-Philippe Champagne said he’s open to speaking to CEOs about it.

“I’ll be happy to engage with them to see what more we can do to attract more investment, create jobs in this country, and make Canada more resilient to face whatever may come next,” he said after the cabinet swearing-in ceremony Tuesday.

The new regulations were initially supposed to take effect in July 2020, but the implementation has been delayed three times due to the COVID-19 pandemic.

“Health Canada is mindful of the impact the COVID-19 situation has on industry to adapt to these new reporting obligations and had delayed the coming into force of these amendments,” the Health Canada spokeswoman wrote.

Health Canada would not say if it plans to bring the regulations into force in January as planned, only that the government remains committed to increase the affordability, accessibility and appropriate use of medicines for Canadians.

This report by The Canadian Press was first published Oct. 28, 2021.

Report Error Submit a Tip

More Stories

‘Women were shortchanged.’ Why bobsledding’s idea of equality doesn’t add up

Kerry Gillespie - Sports Reporter, Toronto Star 7 minute read Preview

‘Women were shortchanged.’ Why bobsledding’s idea of equality doesn’t add up

Kerry Gillespie - Sports Reporter, Toronto Star 7 minute read Saturday, Dec. 4, 2021

When female bobsledders pushed for an Olympic four-woman event, they got a solo discipline instead: monobob. Now they’ll race for the same number of medals as men, but with fewer sledders. Not the progress they were looking for.

Read
Saturday, Dec. 4, 2021

Prairie opportunists are knocking and prime minister should answer the door

Dan Lett 6 minute read Preview

Prairie opportunists are knocking and prime minister should answer the door

Dan Lett 6 minute read Tuesday, Oct. 29, 2019

In preparation for Halloween, Alberta Premier Jason Kenney and Saskatchewan Premier Scott Moe have spent an inordinate amount of time rattling their chains and howling like indignant spirits about the raw deal they are getting from the rest of the country.

In the wake of a federal election in which the governing Liberals failed to elect a MP in either province, Kenney and Moe are summoning apocalyptic visions of secession. We've heard a lot of that before but Western separatists, inspired by the Alberta and Saskatchewan first ministers, are warning everyone that this time it's serious.

Now, before anyone gets too spooked, it's important to remember that a good politician is — first and foremost — an opportunist. These are the folks with the pure political instinct to recognize a moment in which they can gain the upper hand and then seize on it like a ravenous dog on a bone. Imagine that, and you'll have a pretty clear picture of what Kenney and Moe are up to.

In short, the two premiers want two big-ticket items from Ottawa.

Read
Tuesday, Oct. 29, 2019

Director Schrader returns to silver screen with complex view of religion and belief

Alison Gillmor 4 minute read Preview

Director Schrader returns to silver screen with complex view of religion and belief

Alison Gillmor 4 minute read Thursday, Jun. 14, 2018

Bleak, wintry and rigorously controlled — until it’s not — this Book of Job-like drama from American filmmaker Paul Schrader looks at the challenges of faith.

The 71-year-old Schrader, known for scripting four Martin Scorsese films (including Taxi Driver and Raging Bull) and for directing his own (including American Gigolo, Affliction and Auto Focus), grew up in a strict Calvinist home — he famously did not see a film until he was 17 — and has always been drawn to stories of agonizing and uncertain redemption.

As the Rev. Toller (Ethan Hawke) wrestles with what it means to lead a righteous life in our badly broken world, his spiritual fate remains in doubt. It is certain, however, that First Reformed marks a cinematic rebirth for Schrader after recent disasters like The Canyons and Dog Eat Dog. Serious, complex and moving, this is not a perfect film, but even its flaws are powerful.

Toller is a solitary man who has come to the ministry late in life, after a family tragedy and a failed marriage. First Reformed, a historic church in upstate New York that was once a stop on the Underground Railroad, has since been reduced to an austerely beautiful tourist shop, more of a museum than a place of worship.

Read
Thursday, Jun. 14, 2018

The politics of place

Robert Coutts 7 minute read Preview

The politics of place

Robert Coutts 7 minute read Saturday, Apr. 17, 2021

From the Introduction to Authorized Heritage: Place, Memory, and Historic Sites in Prairie Canada, by Robert Coutts, published by University of Manitoba Press

Landscape as culture. It is a concept that at first glance seems peculiar.

Upon reflection, however, we realize that our Western view of landscape is the result of shared values and shared culture, a culture assembled from a rich accumulation of myths, folklores, events, and memories. Such landscapes of memory are cultural memories, and we all experience place and memory in different ways.

One of my own encounters came from historical interest rather than personal familiarity. It was in August of 1983 that I found myself with a small group of people in a boat heading to Hudson Bay. We were travelling on the Hayes River in northern Manitoba, bound for York Factory, the once great trading post and entrepôt of the Hudson’s Bay Company. Leaving from the junction of the Fox and Hayes rivers about 120 kilometres southwest of Hudson Bay, we travelled the river in the warm summer sunshine as the topography of the lowlands became flatter, the riverbank grew steeper, and the fir trees appeared smaller and stunted, bent low by the winter winds off the bay.

Read
Saturday, Apr. 17, 2021

Carrying a torch for tiki

Eva Wasney 5 minute read Preview

Carrying a torch for tiki

Eva Wasney 5 minute read Monday, Nov. 15, 2021

A paper tiki mask is the only indication that the door it’s affixed to leads somewhere other than a dive bar. Ring the doorbell and walk through the kitchen, however, and you’ll be transported to an island-themed lounge that’s equal parts kitschy and comfortable.

“This is just from people’s houses, like my mom’s,” says Allan Pineda, pointing to the wood carvings, water-buffalo horns and rattan furniture decorating the room. “A lot of the stuff you see in here, you’d see in a Filipino’s house back in the day — like second-wave immigrants in the ‘60s and ‘70s, they’d bring this stuff home (from the Philippines).”

Pineda is a local chef and part of the team behind the Bahay Kubo Tiki Bar, a pop-up Filipino drinking and dining experience hosted weekly at an undisclosed Winnipeg establishment.

The details are hush-hush because the temporary eatery is meant to operate like a speakeasy. The dinners are an offshoot of Baon Manila Nights, which Pineda started as a way to highlight Winnipeg’s Filipino culinary scene.

Read
Monday, Nov. 15, 2021

Critics ask cabinet to stop drug-price overhaul

Laura Osman, The Canadian Press 5 minute read Preview

Critics ask cabinet to stop drug-price overhaul

Laura Osman, The Canadian Press 5 minute read Thursday, Oct. 28, 2021

OTTAWA - Critics of a major drug-price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January.

The Patented Medicine Prices Review Board (PMPRB) is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs.

The overhaul has drawn the disapproval of patient groups and drug manufacturers, as well as some pharmacists, doctors, academics and even provincial governments.

On Tuesday, Prime Minister Justin Trudeau put a new minister, Jean-Yves Duclos, in charge of Health Canada, which oversees the file.

Read
Thursday, Oct. 28, 2021